Our Experience

US Biotech

Allogeneic cell therapy for muscular dystrophy. Tech transfer in of their process and cGMP production / QC release. On-going collaboration since 2021.

German Biotech

Process development, validation, production and QC assessments. Preclinical stage for cartilage damage.

Scandinavian Biotech

Process development & clinical Phase II production and QC release for diabetes.

Polish University Clinic

Collaboration since 2017. Production and QC testing of autologous ATMP for clinical trial Phase I/II in dermatological indications.